Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Q12023
Sort By
Newest First
Sign in
1 / 1
1 / 1
Consulting
Supporting Drug Development – Increasing Probability of Success
Nick Davies; Beth Lindsey; Ian Smart
Verta Life Sciences
PAO-03-23-CL-04
Mar 24, 2023
Tumor Microenvironment
Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies
Gil Efron
Purple Biotech
PAO-03-23-CL-01
Mar 21, 2023
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
Denis Dufrane, M.D., Ph.D.
PAO-03-23-CL-06
Mar 20, 2023
Point of Care
Helping Clinicians Make Better Decisions More Easily
Matt Titus
epocrates
PAO-03-23-CL-05
Mar 16, 2023
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
Chris Berger; Kilian Witzel
Avid Bioservices
PAO-02-23-CL-03
Mar 14, 2023
Digital Twin Technology
The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-23-NI-02
Mar 07, 2023
FDA New Drug Approvals
Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-03
Mar 07, 2023
Interchangeable Biosimilars
The Opportunities and Challenges Posed by Biosimilar Interchangeability
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-01
Mar 07, 2023
Scale-Up
Scale-Up Expertise to Support Your Biologics Life Cycle
Pramthesh (Prem) Patel, Ph.D.
Avid Bioservices
PAO-02-23-CL-06
Mar 02, 2023
Bioprinting
The Right Materials for Success in Bioprinting
Elena Meurer; Mariya Gromova
Biopharma Excellence
PAO-02-23-CL-05
Feb 15, 2023
Clinical Trials
Early Reports of Positive Experiences with EMA’s New Clinical Trials Information System
Kieran O’Donnell; Nicola Kidman
PAO-02-23-CL-02
Feb 15, 2023
Lipid Nanoparticles
Lipid Nanoparticles: Transforming the Nanomedicines Market
Antonio Costa, Ph.D.
DIANT Pharma
PAO-02-23-CL-01
Feb 07, 2023
Antibody Production
From Llamas to Yeast: Producing Functional Therapeutic Antibody Fragments in Saccharomyces cerevisiae
Phenotypeca
PAO-01-23-CL-05-153
Feb 01, 2023
Gene Tools
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
David Alvaro, Ph.D.; Jon Moulton, Ph.D.
Pharma's Almanac
PAO-01-23-CL-05
Feb 01, 2023
Cell Therapy
Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-23-NI-01
Jan 31, 2023
Anti-Idiotype Antibodies
Rapid Supply of Anti-Idiotype Antibodies Facilitates Preclinical and Clinical Antibody-Based Drug Development
Na Li, Ph.D.
Sino Biological
PAO-01-23-CL-01
Jan 13, 2023
